QuantLogix Investor Profile

Back to investors

RA Capital Management

Multi-stage healthcare/biotech crossover investor and company builder.
VC Bio/Healthcare 📍 Boston, MA Founded 2002
AUM
$13B
as of 2026-Q1
MID
RA Capital Management is a Boston-based evidence-based, multi-stage healthcare and 'planetary health' investor and company builder, founded in 2002 by Peter Kolchinsky and Rajeev Shah. It invests from private seed rounds through the public markets and managed about $12.6 billion as of March 2025. Portfolio companies include Biohaven, Blueprint Medicines, Apogee Therapeutics, Crinetics and Werewolf Therapeutics.

Firm Profile

Firm Type
VC
Subtype
Bio/Healthcare
Founded
2002
HQ
Boston, MA
Country
USA

Notable Partners

Peter KolchinskyRajeev Shah

Portfolio Companies (5)

biohavenblueprint medicinesapogee therapeuticscrinetics CRNXwerewolf therapeutics

Investment Focus

Stages
Seed · Series A · Series B · Crossover
Sectors
Bio · Healthcare
BioCrossover
Investor data reflects publicly disclosed AUM, fund sizes, and portfolio holdings as of 2026-Q1. Refreshed periodically.